Neuro-Ophthalmologic Symptoms Associated With the Moderna mRNA COVID-19 Vaccine: A Case Report.
| Autor: | Raxwal T; Preventive Medicine, Access Health Care Physicians, Zephyrhills, USA., Akel Z; Medical School, Florida State University, Tallahassee, USA., Naidu J; Internal Medicine, HCA Florida Trinity Hospital, Trinity, USA., Sundaresh K; Infectious Diseases, HCA Florida Trinity Hospital, Trinity, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cureus [Cureus] 2022 Aug 29; Vol. 14 (8), pp. e28523. Date of Electronic Publication: 2022 Aug 29 (Print Publication: 2022). |
| DOI: | 10.7759/cureus.28523 |
| Abstrakt: | Multiple neuro-ophthalmological symptoms, such as visual field defects, optic neuritis, and eye movement abnormalities, have been reported with coronavirus disease 2019 (COVID-19) infection. It is unknown whether the COVID-19 vaccine can result in similar neuro-ophthalmological symptoms post-vaccination. Here, we describe a case of optic neuritis after the administration of the mRNA COVID-19 Moderna vaccine. A 47-year-old female presented eight days after receiving the first dose of the Moderna COVID-19 vaccine with impaired vision in the left eye and symptoms consistent with optic neuritis. The patient underwent a workup for infectious etiology, autoimmune diseases, and allergies, which was negative. The patient was treated with a high dose of steroids resulting in the complete resolution of her symptoms. The patient was recommended against the second dose of the mRNA COVID-19 vaccine. Early detection and treatment of optic neuritis are important to prevent the long-term sequelae of neuritis with impaired vision. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2022, Raxwal et al.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|